- UT Medicine launches Epic ahead of new academic medical center
- Ohio system names COO
- Buy, sell or fight: The new calculus of health system growth
- OpenAI’s growing healthcare footprint
- Tennessee optometrist pleads guilty to $6.9M Medicare fraud
- Why Cook County Health’s Medicaid coverage loss strategy is drawing attention
- Akron Children’s chosen for former Ohio college campus site
- Fitness wearable Whoop rolls out virtual clinician visits, EHR integration
- Surgery Partners doubles down on orthopedics, robotics as total joint growth hits 14.6%
- The growing war over Anthem’s out-of-network penalty policy
- New Jersey system, university create college of community health
- 3 PDS Health headlines to know in 1 week
- 67 health systems ranked by net income
- 46 recent hospital, health system executive moves
- Remarks at the Conference on Financial Market Regulation
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Could ASCs help cardiology move past its ‘breaking point’?
- 3 programs expanding the anesthesia workforce in 2026
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- UVM Health targets $300M in cuts, outpatient overhaul amid $280M deficit
- Maine behavioral health provider cites industry pressures in merger
- Dentists opening practices in 1 month
- The Aspen Group names new chief commercial officer
- Georgia mental health provider adds after-hours outpatient program
- 5 data breaches, settlements impacting cardiology
- Maine hospital adds stroke prevention, cardiac imaging services
- Real estate platform acquires Florida MOB for $28.5M
- Oregon governor signs behavioral health workforce expansion bills amid shortage
- Remarks at the Special Competitive Studies Project AI+ Expo
- Missouri system expands interventional cardiology services
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- 5 DSOs making headlines
- Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
- Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- Op-ed: It's time to make more strategic bets on AI in healthcare
- Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- Exposure Therapy Can Successfully Ease Peanut Allergies
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Revisiting Pharma’s tariff reality
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- AbbVie’s Skyrizi beats out J&J’s Tremfya in in April drug ad spending leaderboard
- Johnson & Johnson launches ‘Generation Fine’ depression project
- Pre-launch efforts linked to lasting drug awareness edge: report
- GSK tees up a Modern Family for meningitis messaging
- NYC invests $12M in overdose recovery workforce
- Aspen Dental to pay $2M to settle allegations of violating corporate dentistry laws
- Texas dental practice relocates into 6K-square-foot facility
- Medit launches global orthodontics division, acquires California training institute
- Pennsylvania enacts dental faculty bill
- Dental industry eyes increased payer oversight, transparency: 4 updates
- Dr. Michael Durbin named president of the American Association of Orthodontists
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- How policy, reimbursement incentives, could help healthcare address its climate footprint
- Remarks at the 13th Annual Conference on Financial Market Regulation
- 5 best practices for financially integrating behavioral health
- Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- New York expands behavioral health data access in EHRs
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- New Hampshire to receive $29.5M in Purdue opioid settlement
- Behavioral health leaders counter HHS ‘overprescribing’ narrative
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Health Tech Weekly Rundown: Tether rolls out medical AI for phones, wearables; Medaptus launches operational ‘command center’
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Alnylam rebuked by FDA over efficacy claims on Amvuttra website
- Insulet CEO details ‘Scrubs’ device promotion win as it boosts awareness, education drive
- Wisconsin releases statewide mental health action plan: 4 things to know
- Alabama behavioral health provider opens outpatient clinic
- Oscar Health's profit hits $679M, membership rises in Q1
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- FDA Authorizes Fruit-Flavored Vapes for Adults
- Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
- FDA rolls out 1-day assessment pilot in bid to refocus inspection resources
- Nearly 8 in 10 employers say GLP-1 coverage drives up benefit costs: Business Group on Health
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- Leapfrog Group's latest safety grades have far fewer low scores since removal of non-participating hospitals
- VR Training Helps Autistic People Navigate Police Encounters
- Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- FDA blocks publication of COVID, shingles vaccine safety studies: NYT
- Bayer diagnoses how to build trust in cell and gene therapies
- Amwell boasts higher than expected renewals, retention despite Q1 revenue decline
- Touting $529B in savings over 10 years, White House looks to expand MFN deals with pharma
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- The timing is right for psychedelics manufacturer Optimi Health's IPO
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- Inside the gaps in fertility and surrogacy systems
- Lilly to invest $4.5B more into massive Indiana manufacturing complex
- CVS execs say company on track to meet MA margin goals by 2028
- Novo Nordisk, Eli Lilly fined by French regulator over obesity drug promotions
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- California hospitals sue Anthem over out-of-network care policy
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- Statement on Proposing Semiannual Reporting
- Wellstar partners with BD to implement AI-driven medication management system
- Listen to the Latest ‘KFF Health News Minute’
- UnitedHealthcare to reduce prior auth requirements by 30%
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- After Alzheimer's agitation nod, Axsome jacks up Auvelity's peak sales projection to $8B
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals
- She Survived 2 Shootings. Research Helps Explain Why Her Pain Persists Years Later.
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
- High-Intensity Exercise After Breast Cancer Surgery Helps Speed Recovery
- Trump Offers Third Candidate For Surgeon General After Pulling Dr. Casey Means' Nomination
Before civilization became unglued in Minnesota, the massive increase in PPACA insurance policy premiums was the fixation in Washington. Those premiums haven't come down or disappeared as a political issue. Joel White of the Council for Affordable Health Coverage (CAHC) has an explanation:
High ACA Premiums Aren’t an Accident, It’s a Business Model for Insurers
By Joel White - January 27, 2026Health care costs are crushing Americans, and Washington keeps pretending it’s a mystery. It isn’t. Obamacare didn’t just fail to give Americans access to care they could afford; it redesigned the system to guarantee insurance companies huge profits. And year after year, Democrats have doubled down on that design, protecting insurers while families pay more for less care.
Affordability is the number one problem in American health care. It’s a problem that crosses party lines. Last week, President Trump introduced The Great Healthcare Plan, designed to lower costs and increase access to care. Health care costs are so out of control that the typical American family will spend 40 percent of their income just on health insurance premiums by 2032. That is not sustainable for any American.
Since the Affordable Care Act (ACA) was enacted, premiums in the individual market have surged by 168 percent, far outpacing employer-sponsored plans, which rose 70 percent, and inflation, at about 40 percent. This year alone, the average ACA family premium is projected to exceed $27,000. Deductibles have nearly doubled as well, meaning families are paying more every month and still pay thousands of dollars in out-of-pocket costs before their coverage even kicks in. In 2026, the deductible for the most popular plan is more than $5,000.
Democrats often respond to this crisis with a familiar solution: more spending. But subsidies haven’t fixed the problem; they’ve made it worse.
Under the ACA, subsidies go to insurance companies and can only be used toward the most expensive plans on the market. As premiums rise, subsidies follow dollar for dollar. Insurers set the prices, and taxpayers guarantee the revenue. Today, 93 percent of ACA enrollees receive subsidies, and taxpayer subsidies per enrollee have increased 56 percent since 2014. According to the Joint Economic Committee, only about one-third of those subsidy dollars directly benefit consumers.
The rest flows straight into insurance company balance sheets.
This is not an accident; it’s an incentive structure. Expanding subsidies and enrolling more people doesn’t pressure insurers to compete or lower prices; it rewards them for charging more. Every premium hike is matched with more taxpayer money. Democrats celebrate higher enrollment numbers while ignoring the reality that the system financially depends on rising costs.
At the same time, the ACA’s anti-market structure has fueled widespread consolidation. One or two insurance companies control the market in most states, pushing out smaller insurers that can’t survive in a system that rewards scale, political influence, and administrative complexity over efficiency and consumer choice.
As competition disappears, so does access to care. Eighty-three percent of enrollees are in narrow-network plans, which limit the hospitals and physicians they can access. Obamacare networks typically include fewer than half of all care providers in an area. This is especially concerning for patients with serious or complex conditions. Families routinely face restricted formularies, denied claims, and endless prior-authorization hurdles. According to the Kaiser Family Foundation, 58 percent of insured Americans experienced a problem with their insurer in the past year, and 73 million claims were denied.
Meanwhile, to avoid Obamacare’s cap on insurance profits, insurance companies have been busy buying hospitals, physician groups, and pharmacies, and paying them more to earn higher profits on services. UnitedHealth Group now generates roughly 42 percent of its revenue, or $136 billion, from internal transactions between its insurance arm and the providers and pharmacy benefit managers it owns. That isn’t care coordination; it’s a monopoly designed to extract profit at every step.
And the profits are staggering. In a recent year, the largest insurers earned more than $71 billion. Insurance CEOs collected nearly $150 million in compensation – all while premiums and out-of-pocket costs kept rising for consumers. The ACA has become a massive transfer of taxpayer dollars to private insurance companies, propped up by policies that Democrats refuse to question.
This is the uncomfortable truth: Democrats claim to stand with patients, but their health care policies protect insurers. They defend a system that rewards size, spending, and consolidation, then act surprised when costs spiral out of control. Every subsidy expansion, every enrollment push, every refusal to introduce real competition locks Americans deeper into a system that treats patients like piggybanks.
There is another path. Congress needs to restore competition by breaking up the insurance and health system monopolies. We need full transparency on prices and quality. If insurers, hospitals, and other service providers refuse to provide prices up front, patients shouldn’t be charged. Consumers should be able to choose any plan that works for them and bring the subsidy with them. If the plan they pick costs less than the subsidy, the difference should be deposited in a Health Savings Account. Insurers would compete for consumers, versus patients being at the mercy of big conglomerates through realigned incentives that ensure health plans and providers only succeed when patients do.
Until that happens, ACA premiums will keep increasing, subsidies will forever increase, insurers will keep cashing in, and working families will keep paying the price for a health care system designed to put profits over patients.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














